Kate L. Feltrin

TL;DR: There are major differences in the effects of intraduodenal C12 and C10, administered at 0.375 kcal/min, on appetite, energy intake, antropyloroduodanal PWs, and gut hormone release in humans.

TL;DR: In healthy women, in healthy women gastric emptying of glucose is slower, and glycemia, plasma GLP-1 and insulin, hunger, and energy intake are less during the follicular compared with the luteal phase; 2) energy intake, glyCEmia, and plasma GLPs, insulin, and insulin are related to gastric emptied; and 3) these parameters are reproducible when assessed twice within a particular phase of the menstrual cycle.

TL;DR: In FD patients, a high-FAT meal induces more symptoms than an isocaloric high-CHO meal, and fasting and postprandial plasma CCK concentrations are greater and PYY concentrations are less, which have important implications for the development of diet-based therapies for the treatment of FD.

TL;DR: It is concluded that the effects of intraduodenal fatty acids on ghrelin, PYY and GLP-2 secretion are dependent on their chain length.

TL;DR: At the doses evaluated, exogenously administered CCK-8 and GLP-1 had discrepant effects on appetite, energy intake, and APD pressures, and the effects of CCk-8+GLp-1, in combination, did not exceed the sum of the results of CCK_8 andGLP_1, providing no evidence of synergism.